Cefixime tablets make return to market

April 30, 2008

Lupin Pharmaceuticals announces manufacture of cefixime 400-mg tablets.

Since 2002, when Lupin Pharmceuticals. Now Lupin has announced they will start making the antibiotic in a 400-mg tablet. Cefixime is the only oral agent currently recommended by the Centers for Disease Control & Prevention for the treatment of uncomplicated urogenital or rectal gonnorhea.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, click here.